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a b s t r a c t
Some orthopoxviruses including cowpox virus embed virus particles in dense bodies, comprised of the
A-type inclusion (ATI) protein, which may provide long-term environmental protection. This strategy
could be beneﬁcial if the host population is sparse or spread is inefﬁcient or indirect. However, the
formation of ATI may be neutral or disadvantageous for orthopoxviruses that rely on direct respiratory
spread. Disrupted ATI open reading frames in orthopoxviruses such as variola virus, the agent of
smallpox, and monkeypox virus suggests that loss of this feature provided positive selection. To test this
hypothesis, we constructed cowpox virus mutants with deletion of the ATI gene or another gene required
for embedding virions. The ATI deletion mutant caused greater weight loss and higher replication in the
respiratory tract than control viruses, supporting our hypothesis. Deletion of the gene for embedding
virions had a lesser effect, possibly due to known additional functions of the encoded protein.
Published by Elsevier Inc.
Introduction
Poxviruses are widely dispersed within vertebrate and insect
species and have evolved alternative strategies for survival and
spread (Damon, 2013; Moss, 2013). Some poxviruses form large
inclusions in the cytoplasm in which mature virions (MVs) are
embedded. Such structures called A-type inclusions (ATIs), Downie
bodies and Marchal bodies by different investigators (Downie,
1939; Goodpature and Woodruff, 1931; Kato et al., 1959; Marchal,
1930) occur within several genera of chordopoxviruses and
entomopoxviruses (Bergoin et al., 1971). It is thought that these
structures prolong infectivity by protecting the embedded virions
from ultraviolet irradiation and other environmental stresses.
Many poxviruses, however, lack the ability to embed virions in
inclusions and depend on the intrinsic stability of the MVs in the
environment or direct animal-to-animal spread. In this regard
orthopoxviruses are notable because some species including cow-
pox virus (CPXV), ectromelia virus, volepox virus and raccoon
poxvirus have ATIs whereas others such as monkeypox virus,
variola virus, vaccinia virus (VACV) and horsepox virus do not.
The gene encoding the ATI protein has been identiﬁed (Funahashi
et al., 1988; Patel and Pickup, 1987) allowing detection of disrupted
ATI open reading frames (ORFs) in many orthopoxviruses that do
not make inclusions. The latter observation suggests that the
common orthopoxvirus ancestor encoded the ATI protein and that
under some circumstances the loss of this feature was a positive or
neutral selection factor that occurred during speciation.
CPXV strains that spontaneously lost the ability to produce ATI
have been isolated by plaque picking (Amano and Tagaya, 1981).
However, no differences in the hemorrhagic and necrotic lesions in
rabbit skin were noted in that brief study. In a more detailed
report, Leite and coworkers (Leite et al., 2011) deleted the gene
encoding the ATI from the Brighton strain of CPXV and compared
replication and pathogenicity of the mutant and parent viruses.
In that study, deletion of the ATI gene had no effect on virus
replication in cell culture but reduced the size and decreased the
histopathology of lesions produced in the ear pinnae. However, the
Brighton strain of CPXV was extensively passaged in cell culture
and has a mutated copy of the gene encoding the p4c protein
(corresponding to the A26L gene of VACV) such that it cannot
produce a full-length protein capable of directing MVs into the
ATIs (McKelvey et al., 2002). Therefore neither the parent CPXV
Brighton nor the mutant embedded virus particles in ATI. In
addition, the antibiotic-resistance and reporter genes used to
replace the ATI ORF were retained in the deletion mutant and
could impact host responses and pathogenicity.
We chose a CPXV strain with intact ATI and A26L homolog
genes that had been isolated from a human infection (Carroll et al.,
2011) for construction of ATI and A26L gene deletion mutants.
Following intranasal (i.n.) infection, the ATI mutant caused greater
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weight loss and increased replication in the respiratory tract
than control viruses providing a possible explanation for positive
selection of orthopoxvirus mutants with disruptions of ATI.
Enhanced replication to a lesser degree was observed with the
A26L mutant.
Results
Initial characterization of the CPXV isolate
The virus chosen for this study, CPXV_GER1991_3 (abbreviated
CPXV 91/3), caused local lesions in humans (Carroll et al., 2011)
and was kindly provided by H. Meyer. Complete genome sequen-
cing had indicated that both the ATI gene (CPXV 149) and the A26L
VACV homolog (CPXV 150) were intact. To demonstrate ATI
formation and the embedding of MVs, HeLa cells were infected
and examined by confocal microscopy. DAPI was used to visualize
DNA in the nucleus and virus factories and the ATI protein was
stained with speciﬁc antibody provided by D. Pickup (Patel et al.,
1986). The ATIs appeared as circles rather than discs within the
cytoplasm because of the inability of the antibody to penetrate the
interior of the structures after chemical ﬁxation (Howard and
Moss, 2012). The ATIs increased in diameter as the infection
progressed (Fig. 1). At 36 h after infection, large ATI occasionally
appeared to be pressing into the nucleus and distorting its shape.
Antibody to the homolog of the VACV A14 protein, which is a
membrane component of MVs, stained particles in factories and
adjacent to ATIs but also could not penetrate the latter structures
after ﬁxation (Fig. 1). ATIs and embedded MVs, however, were
visualized by electron microscopy of infected cell sections and will
be shown below.
CPXV 91/3 was propagated in BS-C-1 cells and virus from
individual plaques was clonally puriﬁed. Stocks were prepared
from three of the clones and compared to the parental virus
following i.n. infection of BALB/c mice. At a dose of 106 plaque-
forming units (PFU), neither the parental virus nor the clonal
isolates caused signiﬁcant weight loss (data not shown). Therefore,
one clonal isolate was chosen as representative for further studies.
In contrast, we conﬁrmed that the commonly used Brighton strain
of CPXV, which is missing the gene needed for embedding MVs
in ATIs, had an LD50 of 2  105 PFU in BALB/c mice (data not
shown), similar to that previously reported (Thompson et al.,
1993).
We considered that the low pathogenicity of CPXV 91/3 might
provide a sensitive model for testing our hypothesis that loss of
ATI formation would enhance virulence.
Construction of ATI and A26 null mutants
We employed a two-step procedure to make ATI (CPXV A149)
and A26L (CPXV A150) gene deletion mutants of the CPXV 91/3
clone (Fig. 2). The ﬁrst step was to replace ORF 149 or ORF 150
with the gene encoding green ﬂuorescent protein (GFP) by homo-
logous recombination. In order to avoid truncation of ORF 148,
which encodes a large subunit of the RNA polymerase and slightly
overlaps ORF 149, the C-terminal six amino acids of ORF 149 were
retained. Following homologous recombination, plaques contain-
ing recombinant viruses were identiﬁed by green ﬂuorescence and
clonally puriﬁed. For the second step we deleted the GFP ORF of
the recombinant viruses to create ATI and A26R null mutants
without the reporter gene. In parallel, we replaced the GFP ORF
with the original ORF to make two revertant controls from the
same clones. The two deletion mutants were named ΔATI and
Fig. 1. Confocal microscopy images of cells infected with CPXV 91/3 showing ATI. HeLa cells were prepared for confocal imaging at 8, 16 and 36 h after infection (hpi). DNA in
nuclei and cytoplasmic factories was stained with DAPI; ATI were stained with a speciﬁc polyclonal antibody; and virus factories and particles were stained with a MAb to
the A14 membrane protein.
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ΔA26 and the revertants ATIRev and A26Rev. DNA sequencing
(not shown) and Western blotting (Fig. 3) were performed to
verify the absence or presence of the ORFs and protein expression,
respectively. The cloned 91/3 parental virus and the revertants
were indistinguishable in all subsequent experiments suggesting
the absence of extraneous alterations that would affect the
phenotypes of either mutant virus.
Electron microscopy of cells infected with CPXV 91/3 and mutants
The production of ATIs by the cloned parental virus was conﬁrmed
by transmission electron microscopy of thin cell sections (Fig. 4A).
Immature virus forms (including crescents, immature virions, and
immature virions with nucleoids) and mature forms (including MVs
and enveloped virions) were present. A higher magniﬁcation image of
an ATI with embedded MVs is shown in Fig. 4B. ATI formed in cells
infected with ΔA26, but no MVs were embedded even though they
were present elsewhere in the cytoplasm (Fig. 4C and D). Immature
andmature virions were found in cells infected with ΔATI, but no ATIs
were detected (Fig. 4E and F). Thus, the mutants behaved precisely as
predicted (McKelvey et al., 2002).
Replication of deletion mutants in cell culture
The replication of the two null mutants and revertants were
similar during a single cycle infection of BS-C-1 cells (Fig. 5A).
Replication was also similar under low multiplicity infection
conditions in which cell to cell spread could occur (Fig. 5B). The
amounts of intracellular and extracellular virus after a low multi-
plicity infection of BS-C-1 (Fig. 5C and D) and mouse embryonic
ﬁbroblasts (MEFs; Fig. 5E and F) were also compared. Replication
in MEFs was investigated in view of the mouse experiments
described below. There was no consistent difference in either
intracellular or extracellular titers of mutant and control viruses.
Pathogencity of deletion mutants in mice
Mice infected i.n. with 106 PFU of parental CPX 91/3, mutant
viruses or revertants exhibited signs of disease including hunched
posture, piloerection and failure to groom. Weight loss data from
two independent experiments were combined for Fig. 6A. During
the second week, mice infected with ΔATI and ΔA26 exhibited
more weight loss than the parental and revertant viruses but this
was statistically signiﬁcant only for ΔATI. There were no deaths
and recovery including weight gain occurred between two and
three weeks. A similar, statistically signiﬁcant pattern of weight
loss for ΔATI compared to the controls was obtained in a third
independent experiment carried out for 10 days (data not shown)
in conjunction with the organ titrations described below.
We also determined the extent of virus replication in the nasal
turbinates and lungs after i.n. infection of BALB/c mice with 106 PFU
of each mutant and the three control viruses. Groups of mice were
sacriﬁced on day 1, 3, 5 and 10 and virus titers in the nasal turbinates
and lungs were determined by plaque assay. With each virus,
replication in the turbinates increased during the ﬁrst 3–5 days
and then plateaued (Fig. 6B). The titers of the clonal parent 91/3 and
the two revertants were nearly superimposable. The titers of both
deletion mutants were higher than the control viruses (po0.05) but
were not signiﬁcantly different from each other.
The lung titers of the clonal parent and the two revertants were
also nearly superimposable, increasing up to day 5 and then
declining (Fig. 6B). In contrast, the ΔATI lung titers were signiﬁ-
cantly higher (po0.05) than the controls and were still three logs
higher on day 10. In the experiment depicted in Fig. 5B, the ΔA26
lung titers were not signiﬁcantly different from the controls. In an
independent experiment (not shown), the ΔATI lung titers were
signiﬁcantly higher than the parental virus and ΔA26; however,
the ΔA26 lung titers were also signiﬁcantly higher than the
parental virus. Other organs titered (liver, brain, spleen and ovary)
had no or few PFUs for any of the infections (data not shown).
Overall, the replication of the viruses in mice were as follows:
ΔATI4ΔA264ATIRev¼A26Rev¼91/3.
Discussion
Why some species of orthopoxviruses embed virions in dense
proteinaceous bodies and others do not have been subject to
speculation. It is reasonable to consider that the ATI provides
protection in the environment and that this contributes to the
survival of the species. This strategy would be particularly impor-
tant if the host population were sparse, host-to-host spread was
inefﬁcient or a host species became locally extinct. However, ATI
may be unnecessary and even disadvantageous at least in the
short term for orthopoxviruses such as variola virus, the agent
of smallpox, that rely on respiratory spread in dense communities.
To test this hypothesis, we obtained a recently isolated CPXV strain
and demonstrated that it made ATIs with embedded virions and
produced relatively mild disease in mice by the i.n. route. Mutants
were constructed with a deletion of the gene encoding the ATI
protein or the VACV A26 homolog that is required for embedding
virions (McKelvey et al., 2002). In addition, revertant viruses were
Fig. 2. Construction of ATI and A26 deletion mutants by homologous recombination:
(A) deletion of ORF 149. The arrangement of ORF 148 (RPO132 RNA polymerase
subunit), ORF 149 (ATI), ORF 150 (VACV A26 homolog) and ORF 151 (VACV A27
homolog) within the CPXV genome is shown. ORF 149 overlaps ORF 148 by 22 nt;
ORF 149 is separated by 44 nt from ORF 150; ORF 150 is separated by 51 nt from ORF
151. The ﬁrst step was replacement of the region, from 39 nt to the right of the start
codon including the ATI promoter to 21 nt preceding the 148 ORF, by the GFP ORF
regulated by the P11 late promoter. In the next step, GFP was removed to create the
ΔATI deletion mutant, in which the stop codon of ORF 148 was separated from the
stop codon of ORF 150 by 5 nt. (B) Deletion of ORF 150. The ﬁrst step was
replacement of the region, from 51 nt upstream of the start codon of ORF 150
including the promoter to the stop codon, by GFP regulated by the P11 late promoter.
The GFP ORF was then removed to create the ΔA26 deletion mutant, in which the
stop codon of gene 151 was separated from the stop codon of 149 by 44 nt.
Fig. 3. Western blot of cells infected with mutant viruses. BS-C-1 cells were
infected with 5 PFU/cell of CPXV 91/3 (lane 1), ΔATI (lane 2), ΔA26 (lane 3),
ATIRev (lane 4), A26Rev (lane 5). After 24 h, the cells were lysed and Western blots
were prepared. Antibody to the ATI protein (ATIp) and the A26 protein (A26p) were
used to detect the corresponding proteins.
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constructed to use as controls. Care was taken to avoid effects on
neighboring genes and a reporter gene, used for initial isolation of
the mutants, was removed at the ﬁnal construction step. Conse-
quently, we could infer that phenotypic changes were due to the
gene deletions exclusively. Electron microscopy conﬁrmed that
the ATI gene deletion virus made no inclusions and that the A26L
gene deletion virus made inclusions but did not embed MVs.
To determine total yields of virus, the infected cell lysates and
medium were sonicated to disperse virus particles. Plaque assays
indicated similar replication of the mutants, parental virus and
revertants in monkey BS-C-1 cells and MEFs.
Although CPXV may spread from rodents to other animals via
skin lesions, we were interested in respiratory spread for the reason
outlined above. The i.n. route of infection has previously been used
to assess CPXV pathogenicity (Bray et al., 2000; Smee et al., 2008;
Thompson et al., 1993). CPXV 91/3 caused only a mild disease when
administered i.n. to BALB/c mice as also recently found by others
using a different mouse strain (Duraffour et al., 2013). However,
mice inoculated i.n. with ΔATI lost signiﬁcantly more weight by
days 10 and 11 than mice inoculated with the parent or revertant.
The ΔA26 mutants caused slightly more weight loss than the
controls but this did not reach signiﬁcance at the dose (106 PFU)
used. In addition, more virus was recovered from the nasal
turbinates of both mutants compared to the parent and revertant
viruses. The lungs of animals infected with ΔATI contained more
virus than those infected with control viruses or ΔA26, correspond-
ing to the greater weight loss of the ΔATI mutant. These results
were consistent with our hypothesis that forming ATI and embed-
ding virions might be disadvantageous for animals that are infected
by the respiratory route. To dispel dual-use concerns, we point out
that ATI mutants occur spontaneously during propagation of CPXV
in cell culture (Amano and Tagaya, 1981) and the 91/3 ATI mutant
caused no deaths in BALB/c mice at 106 PFU whereas the commonly
used Brighton strain of CPXV has a LD50 of 2  105 PFU.
Leite and coworkers (Leite et al., 2011) constructed and char-
acterized an ATI deletion mutant of the Brighton strain of CPXV.
Fig. 4. Transmission electron microscopy of cells infected with parental and mutant viruses. BS-C-1 cells were infected with CPXV 91/3 (A, B), ΔA26 (C, D) and ΔATI (E, F) for
18 h and thin sections were imaged by transmission electron microscopy. Abbreviations: MV, mature virion; IV, immature virion; Nu, IV with a nucleoid; c, crescent; N,
nucleus. Magniﬁcations are indicated at the bottom of each panel.
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There are several important differences between their study and
ours. First, since the Brighton strain has a disrupted A26R ORF,
their parental virus would be comparable to our A26R deletion
mutant and their ATI mutant would be equivalent to a double ATI/
A26R deletion, which we did not make. Second, in the earlier
study, pathogenicity was evaluated following an intradermal
injection of 105 PFU into the ear pinna, rather than by a respiratory
route. The skin lesions produced by the ATI deletion mutant had a
smaller area of necrosis that healed faster than those of the parent
virus, and had more inﬂammatory cells. More virus was recovered
from ear pinnae of the parent virus than the ATI deletion mutant
on days 5 and 8 and less virus on day 11, although there was no
correlation between lesion severity and virus titer. The authors
(Leite et al., 2011) suggested that an immune response to the ATI
protein may account for the greater necrosis.
We considered several explanations to account for the increased
virus replication in mice infected i.n. with ΔATI and ΔA26 CPXV
mutants. It seems likely that virions embedded in the dense ATI would
be less infectious within a host than free MVs. Even a small increase in
virus spread, not readily detected in cell culture, over multiple rounds
of infection in an animal might signiﬁcantly enhance virulence.
However, if that were the sole effect, then one might expect the ΔATI
and ΔA26 mutants to be equivalent. The apparently greater virulence
of the ATI mutant suggests that additional factors may have a role for
ΔA26. It is known that the A26 protein has multiple functions. For
example, A26 on MVs binds to the extracellular protein laminin to
enhance attachment to some cells (Chiu et al., 2007) and to the A27
protein (Ching et al., 2009; Howard et al., 2008), which binds to
glycosaminoglycans to mediate cell attachment (Ching et al., 2009;
Chung et al., 1998). The A26 protein may also regulate fusion of viral
Fig. 5. Replication of parental CPX 91/3, mutants and revertants in BS-C-1 cells and MEFs: (A) BS-C-1 cells were infected with 5 PFU/cell of parental 91/3 clone, ΔATI, ΔA26,
ATIRev or A26Rev. At the indicated times, the cells were lysed and combined with the medium and virus titered. (B) BS-C-1 cells were infected with 0.05 PFU/cell of the
indicated viruses and the cells and media were obtained at the indicated times and titered. (C, D) BS-C-1 cells were infected as in panel B but virus yields of cells alone and
medium alone are shown in panels C and D, respectively. (E, F) MEFs were infected with 0.05 PFU/cell of the indicated viruses and virus yields of cells alone and medium
alone are shown in panels E and F, respectively. Virus titers were obtained by plaque assay on BS-C-1 cells in duplicate from three separate infections (panels A, B, E, F) or two
separate infections (panels C, D). Standard error bars (plus) are shown for panels A, B, E and F.
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and cell membranes (Chang et al., 2010, 2012). Thus, additional roles
for A26may attenuate the otherwise positive effect of the deletion and
may account for its preservation in all orthopoxvirus species. Another
possibility to account for the greater replication of the ΔATI than ΔA26
is that synthesis of the abundant ATI protein consumes resources that
could be used for synthesis of other proteins in its absence. Puriﬁed
ATIs are immunogenic (Patel et al., 1986), but whether antibody or cell
mediated immune responses to ATI during an infection contributes to
clearing of virus is unknown.
In conclusion, our hypothesis that deletion of the ATI gene
enhances orthopoxvirus respiratory infections was supported by
studies of CPXV infection of mice. This advantage could have
provided selective pressure during the evolution of variola virus in
humans and monkeypox virus in rodents.
Materials and methods
Virus
CPXV_GER1991_3 (abbreviated CPXV 91/3) (Carroll et al., 2011),
kindly provided by H. Meyer, was propagated in BS-C-1 or HeLa
cells grown in Earle0s minimal essential media (EMEM) supple-
mented with 2 mM glutamine, 100 mg/ml streptomycin, 100 U/ml
penicillin, and 2% fetal bovine serum.
Construction of virus mutants by recombination
PCR products containing GFP regulated by the P11 late promo-
ter ﬂanked by 400–500 bp of DNA corresponding to the sequences
ﬂanking the ATI and A26R ORFs of CPXV 91/3 were prepared by
standard methods. HeLa or BS-C-1 cells were infected with 0.05
PFU/cell of CPXV 91/3 and 2 h later were transfected with the
PCR products complexed with lipofectamine 2000 in Optimem
medium (Invitrogen). The Optimem was replaced with EMEM
without antibiotics or serum after an additional 6 h. The cells
were harvested and lysed after 2 days and dilutions were plated
on BS-C-1 cells, which were overlaid with agar. Virus was isolated
from ﬂuorescent plaques and the procedure was repeated until
the virus was clonally pure. The next step was to delete GFP by
recombination, with the same ATI or A26L ﬂanking sequences
used above, to create the null mutants ΔATI and ΔA26 without an
exogenous reporter gene. In addition, revertant viruses were made
by replacing GFP with the original ATI or A26L ORFs. PCR and DNA
sequencing were used to conﬁrm clonal purity.
Virus yields
BS-C-1 cells and MEFs were infected at a multiplicity of 5 or 0.05
PFU/cell as indicated in ﬁgure legends. After 1.5 h, the cells were
washed twice with phosphate buffered saline and fresh medium
was added. Cells were collected by scraping and resuspending them
Fig. 6. Virulence of CPXV mutant and revertant strains in mice: (A) weight loss comparison. BALB/cJ (5–7 weeks old) mice were inoculated i.n. with PBS (mock) or 106 PFU of
the cloned CPXV 91/3, the two deletion mutants (ΔATI and ΔA26) and the two revertants (ATIRev and A26Rev). The weight loss data (average weight loss with standard error
of the means) was generated from two independent experiments with a total of 15 mice and plus error bars are shown. The baseline used for calculation was obtained by
weighing each mouse on the two successive days prior to infection. The asterisks indicate signiﬁcant difference (po0.05) between the weight loss of mice infected with ΔATI
and each of the other viruses. (B) Virus titers in organs. Mice (n¼5 per group) were infected as in panel A and sacriﬁced on days 1, 3, 5 and 10. The lungs and nasal turbinates
were homogenized and the virus titers determined by plaque assay on BS-C-1 cells. The average titers (total for the turbinates and per gram for the lung) with standard error
of the means were calculated and the plus bars are shown. For turbinates, asterisks on day 3 of ΔATI infection and 3, 5 and 10 of ΔA26 infection indicate signiﬁcant
differences (po0.05) from CPXV 91/3, ATIRev and A26Rev. For lungs, asterisks on days 3, 5 and 10 of ΔATI infection indicate signiﬁcant differences (po0.05) from CPXV 91/3,
ATIRev, A26Rev and ΔA26.
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in the culture medium and lysed by three freeze and thaw cycles
with vortexing. In other experiments, the cells and medium were
collected separately. Tubes containing the lysates were immersed in
wet ice in a bath sonicator and pulsed three times. Virus titers were
determined by diluting duplicates in supplemented EMEM and
plaque titration on BS-C-1 cells. After a 2 h adsorption, the cells
were overlaid with medium containing methylcellulose. Cells were
stained with crystal violet after 2 days and plaques were counted.
Statistical analysis was done using Prism with 2-way ANOVA with
multiple comparisons and Tukey0s correction for multiple compar-
isons with signiﬁcance set at values less than 0.05.
Western blotting
BS-C-1 cells were infected with 5 PFU/cell of virus. After 24 h
the cells were resuspended in 2 NuPage lithium dodecyl sulfate
loading buffer with 1 reducing agent (Invitrogen). The lysates
were dispersed by sonication, heated at 70 1C and loaded on a
4–12% Bis-Tris sodium dodecyl sulfate polyacrylamide gel in
NuPage morpholinepropanesulfonic acid running buffer (Invitrogen).
Proteins were transferred electrophoretically to a nitrocellulose
membrane (Invitrogen iBLOT) and detected with either polyclonal
antibody to an A26 peptide or antiATI polyclonal antibody (McKelvey
et al., 2002) received from D. Pickup (Duke University) and anti-
rabbit IgG conjugated with peroxidase (Thermo Scientiﬁc). Blots
were developed using the Femto detection system.
Confocal microscopy
HeLa cells adhered to cover slips were infected with 5 PFU/cell
for 36 h and ﬁxed with 4% paraformaldehyde and permeabilized
with 0.1% Triton X-100. Primary staining was performed using
antiA26 and antiATI polyclonal antibody (McKelvey et al., 2002),
and mouse antiA14 MAb (Meng et al., 2011). Secondary staining
was with anti-rabbit IgG and anti-mouse IgG (Invitrogen). Cover-
slips were stained with DAPI and mounted on glass slides using
Prolong Gold mounting media (Invitrogen). Images were acquired
using a Leica SP2 inverted four-channel microscope.
Electron microscopy
BS-C-1 cells in 60 mm diameter plates were infected with virus
at 5 PFU/cell and incubated for 21 h prior to ﬁxation with 2%
glutaraldehyde/0.1 M sodium cacodylate buffer, washed in 0.1 M
sodium cacodylate buffer, post-ﬁxed with reduced osmium tetr-
oxide, and washed in buffer. Cells were dehydrated in a series of
ethyl alcohol: 50%, 70%, 100% and then propylene oxide. The
samples were embedded in EMbed 812 and sections were cut on
a Leica EM UC7 ultramicrotome (Leica Microsystems Inc., Buffalo
Grove, IL). Thin sections were stained with 7% uranyl acetate in
50% ethanol and then 0.01% lead citrate. Sections were reviewed
and photographed on the Tecnai G2 Spirit transmission electron
microscope (FEI, Hillsboro, Oregon) ﬁtted with a Gatan CCD
camera. Chemicals were purchased from Electron Microscopy
Sciences (EMS), Hatﬁeld, PA.
Mouse infection and necropsy
Virus was puriﬁed from infected cell lysates by sedimentation
through a 36% sucrose cushion. Groups (n¼5–10) of 7-week old
BALB/c mice were anesthetized with isoﬂurane and infected i.n.
with 10 ml of virus diluted in phosphate buffered saline with 0.05%
bovine serum albumin. Mock-infected mice were anesthetized and
inoculated with 10 ml of the diluent. Mice were weighed daily for
2 days before infection and each day after infection. Weight loss
was analyzed for signiﬁcance using PRISM 2-way ANOVA with
Tukey0s correction for multiple comparisons. Mice were sacriﬁced
by carbon dioxide and cervical dislocation for necropsy and
collection of the spleen, ovary, liver, lung, cervical lymph nodes,
brain, and nasal turbinates. Tissues collected were placed in a
balanced salt solution containing 0.1% bovine serum albumin,
weighed, and stored at 80 1C. The organs, were thawed, homo-
genized with a tissue grinder and sonicated on ice. Dilutions were
made in supplemented EMEM and a plaque assay was performed
on BS-C-1 cells. Statistical analysis of tissue viral titers was
conducted using PRISM multiple t-tests with Sidak-Bonferroni
correction for multiple comparisons.
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